A case of vesiculobullous dermatomyositis with anti-NXP-2 antibody without malignancy
Modern Rheumatology Case Reports · 2025
DOI: 10.1093/mrcr/rxae037 ↗Kurz gefasst
Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2025. Verfasst von Ryota Naito und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Dermatomyositis, Autoantibodies, Skin Diseases, Vesiculobullous, RNA-Binding Proteins. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Vesiculobullous dermatomyositis (VD) is a rare manifestation of dermatomyositis (DM) and has been suggested to be associated with malignancy. Although the myositis-specific autoantibodies are associated with distinct clinical presentations of DM, those associated with VD remain unclear. Here, we present the case of a 54-year-old man with VD who tested positive for antinuclear matrix protein 2 (NXP-2) antibodies, one of the DM-specific autoantibodies. Serological and histopathological findings did not support autoimmune blistering disease. Physical and histological findings suggested that the severe oedema in combination with the interface dermatitis of DM contributed to blister formation. Although a systemic examination was performed, no evidence of malignancy was found. Following initiation of immunosuppressive therapy, the patient showed significant improvement in both skin lesions and myositis. This case represents the first report of anti-NXP-2-positive VD without malignancy or autoimmune blistering disease. Subcutaneous oedema, a characteristic feature of anti-NXP-2-positive DM, could be related to the formation of VD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan.
- Department of Dermatology, Hyogo Medical University, Hyogo, Japan.
- Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
ORCID-Profile: Ryota Naito, Ryosuke Hiwa, Kosaku Murakami, Naoko Okiyama, Ichizo Nishino, Mirei Shirakashi, Hideaki Tsuji, Ran Nakashima, Hajime Yoshifuji
Zitieren
APA
Naito, R., Hiwa, R., Inaba, R., Murakami, K., Kitoh, A., Kaku, Y., Murata, T., Ichimura, Y., Okiyama, N., Nishino, I., Shirakashi, M., Onizawa, H., Tsuji, H., Kitagori, K., Akizuki, S., Nakashima, R., Onishi, A., Tanaka, M., Yoshifuji, H., & Morinobu, A. (2025). A case of vesiculobullous dermatomyositis with anti-NXP-2 antibody without malignancy. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxae037
Vancouver
Naito R, Hiwa R, Inaba R, Murakami K, Kitoh A, Kaku Y, et al. A case of vesiculobullous dermatomyositis with anti-NXP-2 antibody without malignancy. Modern Rheumatology Case Reports. 2025. doi:10.1093/mrcr/rxae037
BibTeX
@article{Naito2025,
author = {Naito, Ryota and Hiwa, Ryosuke and Inaba, Ryuta and Murakami, Kosaku and Kitoh, Akihiko and Kaku, Yo and Murata, Teruasa and Ichimura, Yuki and Okiyama, Naoko and Nishino, Ichizo and Shirakashi, Mirei and Onizawa, Hideo and Tsuji, Hideaki and Kitagori, Koji and Akizuki, Shuji and Nakashima, Ran and Onishi, Akira and Tanaka, Masao and Yoshifuji, Hajime and Morinobu, Akio},
title = {A case of vesiculobullous dermatomyositis with anti-NXP-2 antibody without malignancy},
journal = {Modern Rheumatology Case Reports},
year = {2025},
doi = {10.1093/mrcr/rxae037}
}
EUVIMED